SRCIN1 and breast cancer: In 2019, a group of researchers reported that the exosomal miR-20a-5p from breast cancer cells could stimulate osteoclast proliferation and differentiation by targeting SRC kinase signaling inhibitor 1 (SRCIN1), a kinase involved in cell migration [124].